Compugen Stock

Compugen CapEx Growth

The Year-over-Year CapEx Growth of Compugen (CGEN) as of Aug 16, 2026 is 159.32 %. In the previous year, Year-over-Year CapEx Growth was -31.40 % — a change of -607.47% (higher).

CapEx Growth

159.32 %

YoY

-607.47%

Last updated:

Year-over-Year CapEx Growth of Compugen is 2026 159.32 % . Year-over-Year CapEx Growth of Compugen was 2025 -31.40 % . It decreases by -607.47% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Year-over-Year CapEx Growth of Compugen is 159.32 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year CapEx Growth Compugen since 2006 – with annual values, charts, and detailed analysis.

CapEx growth measures the percentage change in capital expenditures. Increasing CapEx can signal investment in future growth capacity.

To evaluate Year-over-Year CapEx Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year CapEx Growth.

Year-over-Year CapEx Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year CapEx Growth's Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen